Corient Private Wealth’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.6M Sell
122,488
-32,406
-21% -$4.25M 0.02% 489
2025
Q4
$12.7M Buy
154,894
+111,077
+254% +$16M 0.01% 693
2025
Q3
$6.46M Buy
43,817
+12,842
+41% +$1.78M 0.01% 632
2025
Q2
$4.01M Sell
30,975
-2,426
-7% -$294K 0.01% 773
2025
Q1
$3.99M Sell
33,401
-3,322
-9% -$412K 0.01% 742
2024
Q4
$4.26M Sell
36,723
-3,810
-9% -$482K 0.01% 749
2024
Q3
$5.47M Buy
40,533
+915
+2% +$122K 0.01% 726
2024
Q2
$5.37M Buy
39,618
+614
+2% +$83.5K 0.01% 688
2024
Q1
$5.04M Buy
39,004
+1,762
+5% +$213K 0.01% 705
2023
Q4
$4.26M Sell
37,242
-734
-2% -$73.3K 0.01% 736
2023
Q3
$3.46M Sell
37,976
-204
-0.5% -$21K 0.01% 734
2023
Q2
$4.3M Buy
38,180
+4,959
+15% +$524K 0.01% 670
2023
Q1
$3.48M Buy
33,221
+6,701
+25% +$700K 0.01% 691
2022
Q4
$2.93M Buy
+26,520
New +$2.78M 0.01% 614

Other funds holding XYL

Corient Private Wealth's XYL Position: Q1 2026 in Review

Corient Private Wealth reduced its Xylem (XYL) stake by 21% in Q1 2026, selling an estimated $4.25M and leaving 122,488 shares worth $14.6M. The position accounts for 0.02% of the portfolio, ranked #489.

Corient Private Wealth first reported a position in XYL in Q4 2022 and has held it in 14 quarters since. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Corient Private Wealth held 122,488 shares of Xylem worth $14.6M as of Q1 2026.
  • Corient Private Wealth sold 32,406 Xylem shares in Q1 2026, an estimated $4.25M.
  • Xylem made up 0.02% of Corient Private Wealth's portfolio in Q1 2026, its #489 holding.
  • Corient Private Wealth first reported a position in Xylem in Q4 2022 and has held it in 14 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.